Gilead Sciences | 資産

株価
152.50
毎日の変更
3.13 2.10%
毎月
22.64%
毎年
58.79%
Q1 予測
147.82




資産 変化する 日付
AbbVie USD 133.9B 3.28B 2025-09
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
ALKERMES USD 2.33B 76.7M 2025-09
Alnylam Pharmaceuticals USD 4.85B 285.64M 2025-09
Amgen USD 90.14B 2.24B 2025-09
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Eli Lilly USD 114.94B 14.01B 2025-09
Gilead Sciences USD 58.53B 2.81B 2025-09
GlaxoSmithKline GBP 61.12B 221M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Incyte USD 6.33B 509M 2025-09
J&J USD 192.82B 573M 2025-09
Merck USD 129.55B 12.02B 2025-09
Moderna USD 12.14B 125M 2025-09
Neurocrine Biosciences USD 4.27B 375.9M 2025-09
Novartis USD 107.29B 2.89B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
United Therapeutics USD 7.35B 556.9M 2025-09
Vertex Pharmaceuticals USD 24.86B 825.6M 2025-09


Gilead Sciences 資産 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.